view4D pharma PLC

4d Pharma PLC - Block Listing Six Monthly Return

RNS Number : 9441Y
4d Pharma PLC
14 September 2020

14 September 2020


4D pharma plc


(the "Company" or "4D")


Block Listing Six Monthly Return


Name of applicant:

4D Pharma plc

Name of scheme:

Block Admission for February 2020 warrants

Period of return:


10 March 2020


9 September 2020

Number of securities originally admitted at date of admission:

22,000,000 Ordinary Shares of 0.25p each on 10 March 2020

Balance of unallotted securities under scheme(s) from previous return:

22,000,000 Ordinary shares

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0 Ordinary shares

Less:  Number of securities issued/allotted under scheme(s) during period:

0 Ordinary shares

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

22,000,000 Ordinary shares


Name of contact:

Duncan Peyton

Telephone number of contact:

Company Secretary (0113 895 0130)



Contact Information:


Duncan Peyton, Chief Executive Officer +44 (0)113 895 0130

Investor Relations [email protected]


N+1 Singer - Nominated Adviser and Joint Broker +44 (0)20 7496 3000

Aubrey Powell / Justin McKeegan / Iqra Amin (Corporate Finance)

Tom Salvesen (Corporate Broking)


Bryan Garnier & Co. Limited - Joint Broker +44 (0)20 7332 2500

Dominic Wilson / Phil Walker


Image Box Communications

Neil Hunter / Michelle Boxall +44 (0)20 8943 4685

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

Quick facts: 4D pharma PLC

Price: -

Market: LSE
Market Cap: -

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


4D Pharma shares could re-test 2016’s £10 highs if they do this one thing

The 4D Pharma (LON:DDDD) share price could go on to re-test last year’s highs of £10 if they can break above the 200-day moving average, claims Zak Mir. “Really, one would want to see the shares break outside that range in order to determine fresh direction,” Mir explains in the Proactive...

on 13/1/17

3 min read